Related Experiment Video
Updated: May 12, 2026

PRP as a New Approach to Prevent Infection: Preparation and In vitro Antimicrobial Properties of PRP
Published on: April 9, 2013
The antimicrobial effects of cord blood-derived platelet gel on nosocomial pathogens
Akbar Hashemi Tayer1, Gholamreza Shokoohi2
1Noncommunicable Diseases Research Center, Jahrom University of Medical Sciences, Jahrom, Iran.
Insights
Umbilical cord blood-derived platelet gel shows strong antimicrobial activity against resistant bacteria like MRSA and fungi. This novel autologous antimicrobial offers a promising new treatment option for infections.
Area of Science:
- Microbiology
- Biotechnology
- Regenerative Medicine
Background:
- Umbilical cord blood-derived platelet gel (CBPG) is a rich source of growth factors and antimicrobial peptides.
- Nosocomial pathogens pose a significant threat in healthcare settings, necessitating novel antimicrobial strategies.
Purpose of the Study:
- To evaluate the in vitro antibacterial and antifungal activity of CBPG against common nosocomial pathogens.
- To determine the Minimum Inhibitory Concentration (MIC) and time-kill kinetics of CBPG.
Main Methods:
- Platelet-rich plasma (PRP) was isolated from umbilical cord blood and activated to form platelet gel (PG).
- Antimicrobial activity was tested against Klebsiella pneumoniae, MRSA, Acinetobacter baumannii, Pseudomonas aeruginosa, Candida albicans, Aspergillus spp., and Penicillium spp. using broth microdilution and time-kill assays.
- Minimum Inhibitory Concentration (MIC) and log10 reduction at 24h were determined.
Main Results:
- PG demonstrated significant bacteriostatic activity against MRSA and K. pneumoniae (MIC 2.2-2.8 × 10^8 platelets/mL; 1.7-1.8 log10 reduction at 24 h).
- No significant antibacterial activity was observed against P. aeruginosa or A. baumannii.
- PG exhibited sustained fungistatic effects against Candida albicans, Aspergillus spp., and Penicillium spp. (MIC: 1.9-4.2× 10^8 platelets/mL up to 72 h).
Conclusions:
- CBPG possesses potent bacteriostatic and fungistatic properties, particularly against multidrug-resistant Gram-positive bacteria.
- CBPG represents a novel autologous antimicrobial agent with potential clinical applications.
- Further research is warranted to explore the therapeutic potential of CBPG in managing nosocomial infections.
Background And Objectives:
Umbilical cord blood-derived platelet gel (CBPG) is rich in growth factors (GFs) and antimicrobial peptides. This study evaluated its in vitro antibacterial and antifungal activity against dominant nosocomial pathogens.
Materials And Methods:
In this experimental study, CB samples were taken from 12 healthy pregnant women post-cesarean at Motahari Hospital, Jahrom. Platelet -rich plasma (PRP) was isolated using a two-step centrifugation protocol (soft-spin: 200×g, 10 min; hard spin:1000×g, 15 min, 22°C) and activated with calcium and human thrombin to form PG. Antimicrobial effect of PG was determined against Klebsiella pneumoniae, Methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter baumannii, Pseudomonas aeruginosa, Candida albicans, Aspergillus spp., and Penicillium spp. using broth microdilution and time-kill assays per CLSI guidelines.
Results:
PG exhibited strong bacteriostatic activity against MRSA and K. pneumoniae (MIC 2.2-2.8 × 108 platelets/mL; 1.7-1.8 log10 reduction at 24 h, p < 0.001), while PRP was moderately active and PPP was ineffective. No significant activity was observed against P. aeruginosa or A. baumannii (p= 0.2). PG showed sustained fungistatic effects (MIC: 1.9-4.2× 108 platelets/mL up to 72 h).
Conclusion:
CBPG exhibits potent bacteriostatic and fungistatic effects, particularly against MDR Gram-positive bacteria, offering a novel autologous antimicrobial.
More Related Videos
10:32Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
12:40Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System
Published on: December 7, 2012
Related Concept Videos
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...